Liqin Ding

机构：Tianjin University of Traditional Chinese Medicine · ORCID：0000-0003-3149-3699

发表论文 121 篇 · 总被引 2203 次 · h-index 29

代表论文

• Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis (2022 · Journal of Controlled Release · 被引 208)
• Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats (2021 · Frontiers in Pharmacology · 被引 120)
• Potential of natural products in inflammation: biological activities, structure–activity relationships, and mechanistic targets (2024 · Archives of Pharmacal Research · 被引 41)
• Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways (2024 · International Immunopharmacology · 被引 35)
• Natural deep eutectic solvents (NADES) in drug delivery systems: Characteristics, applications, and future perspectives (2025 · International Journal of Pharmaceutics · 被引 32)
• Bacteriophage SRD2021 Recognizing Capsular Polysaccharide Shows Therapeutic Potential in Serotype K47 Klebsiella pneumoniae Infections (2021 · Antibiotics · 被引 32)